Camden Partners has closed its debut venture capital fund investing in biotechnology companies from Maryland. George Petrocheilos, a partner at Baltimore private equity firm, said the Nexus Fund has invested in six companies since its launch last year. Ultimately, the fund will invest in about 10 companies providing between $1,000 and $2.25 million per company. Petrocheilos declined to disclose the size of the fund and the names of investors. Petrocheilos co-founded Nexus last year with R. Jacob…
from https://www.bizjournals.com/baltimore/news/2017/12/21/camden-partners-closes-biotech-venture-capital.html?ana=RSS&s=article_search
via http://baltimorecheckbook.tumblr.com/post/168794386142
No comments:
Post a Comment